Y.-H. Ling
Impact in
- Toxicology top 10%
-
- Colorectal Cancer Treatments and Studies
- Cancer-related Molecular Pathways
- Cancer Treatment and Pharmacology
Papers in
-
- Cancer therapeutics and mechanisms 3
- DNA Repair Mechanisms 3
- Glycosylation and Glycoproteins Research 2
- Oncology 10
- HER2/EGFR in Cancer Research 7
- Colorectal Cancer Treatments and Studies 4
- Cancer Treatment and Pharmacology 4
- Co-authors
- Waldemar Priebe (2 shared papers)Román Pérez-Soler (5 shared papers)Kenneth L. Beattie (2 shared papers)Jay A. Nelson (2 shared papers)Jenny Chan (1 shared paper)Bilal Piperdi (2 shared papers)Glenn S. Kroog (2 shared papers)Tianhong Li (2 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Molecular Pharmacology (2 papers)JNCI Journal of the National Cancer Institute (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Free Radical Research (1 paper)
- Partner nations
- United StatesChinaItaly
In The Last Decade
Y.-H. Ling
24 papers receiving 568 citations
Peers
Comparison fields: 5 of 79
- Toxicology 31
- Oncology 226
- Molecular Biology 333
- Cancer Research 44
- Pulmonary and Respiratory Medicine 84
Countries citing papers authored by Y.-H. Ling
This map shows the geographic impact of Y.-H. Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y.-H. Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y.-H. Ling more than expected).
Fields of papers citing papers by Y.-H. Ling
This network shows the impact of papers produced by Y.-H. Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y.-H. Ling. The network helps show where Y.-H. Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Y.-H. Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. | 1993 | 160 |
| 2 | 1998 | 58 | |
| 3 | 1992 | 54 | |
| 4 | 3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells. | 1998 | 42 |
| 5 | In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranes. | 1993 | 33 |
| 6 | 2006 | 29 | |
| 7 | 1991 | 28 | |
| 8 | 2004 | 27 | |
| 9 | 2007 | 22 | |
| 10 | 1990 | 17 | |
| 11 | 2012 | 13 | |
| 12 | 2004 | 12 | |
| 13 | 2007 | 12 | |
| 14 | 2004 | 11 | |
| 15 | EGF receptor and p21WAF1 expression are reciprocally altered as ME-180 cervical carcinoma cells progress from high to low cisplatin sensitivity. | 2000 | 11 |
| 16 | 2014 | 10 | |
| 17 | 2004 | 10 | |
| 18 | Effects of homoharringtonine on protein glycosylation in human bladder carcinoma cell T-24. | 1989 | 9 |
| 19 | 2016 | 8 | |
| 20 | 1998 | 8 |
About Y.-H. Ling
Y.-H. Ling is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pulmonary and Respiratory Medicine and Surgery, having authored 24 papers that have together received 582 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (7 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (4 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer therapeutics and mechanisms (3 papers), DNA Repair Mechanisms (3 papers), Synthesis and biological activity (2 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Toxicology (31 citations), Oncology (226 citations), Molecular Biology (333 citations), Cancer Research (44 citations) and Pulmonary and Respiratory Medicine (84 citations). Y.-H. Ling has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Waldemar Priebe, Román Pérez-Soler, Kenneth L. Beattie, Jay A. Nelson, Jenny Chan, Bilal Piperdi, Glenn S. Kroog, Tianhong Li, Guillermina Lozano and Waun Ki Hong. Their work appears in journals such as Journal of Clinical Oncology, Molecular Pharmacology, JNCI Journal of the National Cancer Institute, Journal of Pharmacology and Experimental Therapeutics and Free Radical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.